---
layout: post
title: "红日药业：公司产品血必净注射液列入新冠肺炎诊疗方案（试行第九版）"
date: 2022-03-16 15:48:08 +0800
categories: emnews
tags: 东财滚动新闻
---
> 红日药业公告，公司产品血必净注射液列入《新型冠状病毒肺炎诊疗方案（试行第九版）》。（财联社）

<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.300026&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" alt="K图 300026_0" data-code="K 300026|0|2" data-code2="K 300026|0|80|" style="border:#d1d1d1 1px solid;" width="578" height="276" border="0" /></p><!-- EM_StockImg_End --><p><span id="stock_0.300026"><a href="http://quote.eastmoney.com/unify/r/0.300026" class="keytip" data-code="0,300026">红日药业</a></span><span id="quote_0.300026"></span><span id="Info.3332"><a href="http://data.eastmoney.com/notices/" class="infokey">公告</a></span>，公司产品血必净注射液列入《新型冠状病毒肺炎诊疗方案(试行第九版)》。<br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finance.eastmoney.com/news/1354,202203162312099451.html>

[返回东财滚动新闻](//finews.withounder.com/emnews/)｜[返回首页](//finews.withounder.com/)